在母亲是心源性休克，肺水肿。
目的分析小儿心源性休克的临床特点和预后。
Objective To explore the clinical features and prognosis of cardiogenic shock in pediatric patients.
目的研究参附注射液对急性心源性休克的治疗作用。
Objective To study the therapeutic effect of Shenfu injection in the treatment of acute cardiogenic shock.
同时在周二我也会介绍有关心源性休克的一些内容。
There are some studies of the different antiplatelet agents, cilostazol, aspirin, it's interesting to hear that's an actually presentation from the Orient.
这是有趣的是佛主的逝世是由于心肌梗塞和心源性休克。
It is gratifying to note that the end of Lord Buddha came due to myocardial infraction and cardiac shock.
经皮介入治疗心源性休克患者临床结果的预测因素都有什么？
My question is what are the predictors of clinical outcome after percutaneous treatment for cardiogenic shock?
方法：对42例老年心源性休克病人的临床资料进行回顾分析。
Method: Retrospectively analysis the clinical datas of 42 old patients .
积极控制血糖，纠正心力衰竭和心源性休克，对减低死亡率有重要的意义。
Positive control of blood sugar, heart failure and corrective cardiogenic shock, to reduce mortality has important significance.
结果表明：心源性休克、心衰及严重心律失常是影响预后的三项主要因素。
The results showed that cardiogenic shock, heart failure and severe arrhythmia were three important factors which affected short-term of AMI.
《国际循环》：您可否谈谈处理心源性休克患者时介入性左室支持装置的使用？
International Circulation: Could you please to talk about percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock?
目的了解急性心肌梗死后心源性休克患者早期发生急性肾衰竭与其预后的关系。
Objective To investigate the relationship between early developed acute renal failure and the prognosis of patients with cardiogenic shock after acute myocardial infarction.
急性紧急梗死伴心源性休克的病人首选治疗是经皮血管重建加冠状动脉搭桥手术。
And the treatment of the patients with acute myocardial infarction complicated with cardiac shock is revascularization percutaneously or with coronary artery bypass surgery.
目的观察主动脉内气囊反搏救治老年重症急性左心衰竭及心源性休克的临床疗效。
Objective To observe the clinical therapeutic effectiveness of intra-aortic balloon pumping (IABP) in the treatment of elderly with serious acute left ventricular failure and cardiogenic shock.
严重心律失常，心源性休克和梗塞扩展在HT组略多（P >0 .0 5 ）。
Severe arrythmia, cardiogenic shock and infarction extension in HT group were slightly more than those in NHT group(P> 0.05).
Windecker教授：心源性休克仍然是非常恶性的疾病，特点是死亡率高。
Windecker: The cardiogenic shock is still a very malignant disease characterized by a high incidence of mortality.
目的探讨主动脉内球囊反搏在介入治疗急性心肌梗死合并心源性休克患者中的作用。
Objective to assess the clinical effect of intra-aortic balloon pump in patients with cardiogenic shock due to acute myocardial infarction.
心源性休克是急性心肌梗死的严重并发症，是引起急性心肌梗死患者死亡的主要原因。
Cardiogenic shock is the serious complication of acute myocardial infarction., it is the leading cause of death for patients with acute myocardial infarction.
本文综述了急性心肌梗死合并心源性休克在定义、发生机制和治疗等方面的研究进展。
In this article, it is reviewed that the advances in research of the definition, etiology and therapy in cardiogenic shock complicating acute myocardial infarction.
目的探讨急性心肌梗死（AMI）合并心源性休克患者的冠脉病变特点及再灌注疗法的效果。
Objective To investigate coronary angiographic findings and the effect of reperfusion therapies in patients with acute myocardial infarction(AMI)complicated with shock.
目的观察依那普利、单纯补液对急性右心室心肌梗死（RVMI）心源性休克时血流动力学指标的作用。
Objective To study the therapeutic effects of Enalapril on hemodynamic indexes in cardiac shock dogs induced by acute right ventricular myocardial infarction(RVMI).
目的：观察消心痛联合补液对急性右心室心肌梗死（RVM I）心源性休克时血流动力学指标的影响。
Objective: To observe the therapeutic effect of isosorbide dinitrate combined with volume loading on hemodynamics in cardiac shock dogs induced by acute right ventricular myocardial infarction(RVMI).
采用综合治疗，对心源性休克、房室传导阻滞者，早期、大量、短时应用肾上腺皮质激素及大剂量维生素C。
Patients with cardiogenic shock and or A-V block received treatment of early administrtion of large dosage of corticosteroids and vitamin C in short period.
目的：小结主动脉气囊反搏术（IABP）在冠状动脉支架术围手术期合并严重心源性休克患者中的应用结果。
Objective:To present the following up result of intraaortic balloon counterpulsation (IABP)for patients with cardiogenic shock during periprocedural coronary stenting.
急性心肌梗塞(ami)是临床引起心源性休克的最常见、最重要的病因，其病情多险重、突变，病死率较高。
AMI is the common and important pathogenic cause for Cardiogenic shock clinically. Its mortality is very high. Patients' condition is very critical and changes abruptly.
于6月16日行冠脉支架植入术，手术顺利。2008年6月19日，患者再发心肌梗死，心源性休克，抢救无效死亡。
On June 16 the good crown arteries support implantation, the surgery is smooth. on June 19, 2008, the patient sends the cardiac arrest again, the heart source shock, rescues the invalid death.
结论对急性心肌梗死患者实施不同再灌注治疗是安全有效的，应重视对合并心源性休克患者开展直接冠状动脉成形术和急症冠状动脉搭桥术。
Conclusions Reperfusion therapy is a safe and effective therapeutic maneuver for patient with AMI, moreover, primary PCI or emergency CABG may be more preferable in cardiac shock patients.
结论对急性心肌梗死患者实施不同再灌注治疗是安全有效的，应重视对合并心源性休克患者开展直接冠状动脉成形术和急症冠状动脉搭桥术。
Conclusions Reperfusion therapy is a safe and effective therapeutic maneuver for patient with AMI, moreover, primary PCI or emergency CABG may be more preferable in cardiac shock patients.
应用推荐